Search and analyze individual stocks with comprehensive metrics

Vasundhara Rasy.

VRLPharmaceuticals & Biotechnology

Fundamental Score

...

Vasundhara Rasy. Share Price & Market Analysis

Current Market Price (CMP)
175.05
No change data available
Market Cap
58.88 (Cr)
Industry
Pharmaceuticals & Biotechnology

Profitability Metrics

Poor

Return on Equity

12.59%
Good

Return on Capital Employed

16.56%
Excellent

Operating Profit Margin (5Y)

13.54%
Average

Dividend Yield

1.08%

Valuation Metrics

Excellent

Price to Earnings

14.94x

Market Capitalization

58.88 (Cr)

Industry P/E

33.97x

Growth Metrics

Poor

YoY Quarterly Profit Growth

-33.72%
Poor

YoY Quarterly Sales Growth

-0.92%
Poor

Sales Growth (5Y)

9.93%
Poor

EPS Growth (5Y)

7.72%
Poor

Profit Growth (5Y)

7.72%

Financial Health

Excellent

Debt to Equity

0.12x
Excellent

Interest Coverage

15.92x
Poor

Free Cash Flow (5Y)

-1.28 (Cr)

Ownership Structure

Good

Promoter Holding

61.98%
Poor

FII Holding

0.00%
Poor

DII Holding

0.00%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
61.98%
Promoter Holding
58.88 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of VRL across key market metrics for learning purposes.

Positive Indicators

6 factors identified

Excellent ROCE Performance (16.56%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.

Attractive Valuation (P/E: 14.94 vs Industry: 33.97)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.

Conservative Debt Levels (D/E: 0.12)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.

Strong Interest Coverage (15.92x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.

Balanced Promoter Holding (61.98%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

3 factors identified

Profit Decline Concern (-33.72%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.

Negative Free Cash Flow (₹-1.28 Cr over 5Y)

Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.

Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.

Small Market Cap

Observation: Higher investment risk due to limited size.

Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.

📊 Educational Market Overview

Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities.

Loading Peer Comparison

Finding companies in the Pharmaceuticals sector...

Financial Statements

Comprehensive financial data for Vasundhara Rasy.

About VRL

Company Details

Symbol:VRL
Industry:Pharmaceuticals & Biotechnology
Sector:Pharmaceuticals

Market Information

Market Cap:58.88 (Cr)
P/E Ratio:14.94
Beta:N/A

Performance

52W High:N/A
52W Low:N/A
Dividend Yield:1.08%

VRL Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)12.59%
Return on Capital Employed16.56%
Operating Profit Margin (5Y)13.54%
Debt to Equity Ratio0.12
Interest Coverage Ratio15.92

Growth & Valuation

Sales Growth (5Y)9.93%
Profit Growth (5Y)7.72%
EPS Growth (5Y)7.72%
YoY Quarterly Profit Growth-33.72%
YoY Quarterly Sales Growth-0.92%

Frequently Asked Questions

What is the current price of VRL?

VRL is currently trading at ₹175.05 with a gain of 0.00% today. The current market price (CMP) represents the last traded price of VRL shares on the stock exchange. This price fluctuates throughout trading hours based on supply and demand. You can track real-time price movements, percentage changes, and trading volume in the header section.

What is the P/E ratio of VRL and what does it mean?

VRL has a P/E ratio of 14.94x compared to the industry average of 33.97x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹15 for every ₹1 of annual earnings. This is lower than the industry average, which might indicate undervaluation or slower growth expectations.

How is VRL performing according to Bull Run's analysis?

VRL has a Bull Run fundamental score of 37.6/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability (ROE: 12.59%), growth metrics, valuation ratios, and financial health indicators. The score updates quarterly with new financial data and helps you quickly assess overall investment quality.

What sector and industry does VRL belong to?

VRL operates in the Pharmaceuticals & Biotechnology industry. This sector classification helps understand the broader economic trends, regulatory framework, and competitive landscape affecting Vasundhara Rasy.. Companies in this industry typically face similar market dynamics, cyclical patterns, and macroeconomic factors. Understanding the industry context is crucial for peer comparison and assessing how sector-specific trends might impact the stock's performance.

What is Return on Equity (ROE) and why is it important for VRL?

VRL has an ROE of 12.59%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Vasundhara Rasy. generates profits from shareholders' equity. An ROE of 13% means the company generates ₹13 profit for every ₹100 of shareholders' equity. This metric is crucial for assessing management's ability to create value for shareholders.

How is VRL's debt-to-equity ratio and what does it indicate?

VRL has a debt-to-equity ratio of 0.12, which indicates conservative financing with low financial risk. This means the company has ₹12 of debt for every ₹100 of equity. This conservative approach provides financial stability but may limit growth potential.

What is VRL's dividend yield and is it a good dividend stock?

VRL offers a dividend yield of 1.08%, which means you receive ₹1.08 annual dividend for every ₹100 invested. The focus appears to be more on growth rather than dividend income. Dividend yield is calculated as annual dividend per share ÷ current share price × 100. Evaluate dividend consistency over 5+ years and free cash flow coverage for sustainability.

How has VRL grown over the past 5 years?

VRL has achieved 5-year growth rates of: Sales Growth 9.93%, Profit Growth 7.72%, and EPS Growth 7.72%. These growth metrics show the company's ability to expand its business and improve profitability over time. Sales growth indicates market expansion, profit growth shows operational efficiency, and EPS growth directly impacts share price appreciation potential.

What is the promoter holding in VRL and why does it matter?

Promoters hold 61.98% of VRL shares, with 0.00% of promoter shares pledged. This high promoter holding indicates strong management confidence and alignment with shareholders. Low pledging indicates financial stability of promoters. Recent change in promoter holding: 0.00%.

How does VRL compare with its industry peers?

VRL trades at P/E 14.94x vs industry average 33.97x, with ROE of 12.59% and ROCE of 16.56%. The stock appears undervalued relative to peers based on P/E ratio. Peer comparison helps identify whether VRL is outperforming its competitive set in profitability, growth, and valuation metrics.

What is VRL's market capitalization and what category does it fall into?

VRL has a market capitalization of ₹59 crores, making it a Mid-cap stock. Mid-cap stocks balance growth potential with moderate risk. Market cap is calculated as current share price × total outstanding shares, representing the company's total market value.

What are the key financial ratios to consider for VRL?

Key ratios for VRL: ROE 12.59% (Good), ROCE 16.56%, P/E 14.94x, Debt-to-Equity 0.12, Interest Coverage 15.92x. These ratios help assess profitability (ROE, ROCE), valuation (P/E), financial health (D/E, Interest Coverage), and overall investment quality. Compare these with industry medians and historical trends for meaningful analysis.

How volatile is VRL stock and what is its beta?

VRL has a beta of N/A, which means it is less volatile than the market and offers defensive characteristics. Beta measures price volatility relative to the Nifty 50. Lower beta stocks provide stability during uncertain market conditions. Consider beta alongside your risk tolerance and portfolio diversification strategy.

What is the 52-week high and low for VRL?

VRL has a 52-week high of ₹N/A and low of ₹N/A. Currently trading at ₹175.05, the stock is within its annual trading range. Trading near highs indicates strong momentum but limited upside potential.

What are the key risks associated with investing in VRL?

Key risks for VRL include: Market volatility (Beta: N/A), financial leverage (Debt-to-Equity: 0.12), and operational challenges. The stock has a Fundamental Score of 37.6/100, indicating higher risk requiring thorough due diligence. Sector-specific risks in Pharmaceuticals & Biotechnology include regulatory changes, economic cycles, and competitive pressures. Consider your risk tolerance, investment horizon, and portfolio diversification before investing. Past performance doesn't guarantee future results.

What is VRL's operating profit margin and how has it trended?

VRL has a 5-year average Operating Profit Margin (OPM) of 13.54%, which is good and shows decent operational efficiency. Operating Profit Margin shows operational efficiency by measuring operating profit as a percentage of revenue. Monitor margin trends to assess management's ability to control costs and improve efficiency. Compare with industry peers to understand relative performance.

How is VRL's quarterly performance in terms of sales and profit growth?

VRL's recent quarterly performance shows YoY Sales Growth of -0.92% and YoY Profit Growth of -33.72%. Growth rates indicate the current business trajectory and market demand. Sales growth shows market demand while profit growth reveals operational efficiency and margin management.

What is the FII and DII holding pattern in VRL?

VRL has FII holding of 0.00% and DII holding of 0.00%, totaling 0.00% institutional ownership. This institutional participation level shows the confidence of professional money managers. Monitor quarterly changes in institutional holdings for investment flow trends and sentiment.